Olfactory Bioscience (OLFC) 0.0538 $OLFC OLFC's Special

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Olfactory Bioscience (OLFC) 0.0538 $OLFC

OLFC's Special Event: $19.95 for All Natural Non-Prescription Effective Medicines for Anxiety, Sleep, Sensory and Spectrum Issues
M2 - Mon Dec 14, 6:33AM CST
Olfactory Biosciences' Special Season One Month Only prices are 60% from regular $ 49.95PHILADELPHIA, PA / Olfactory Biosciences Corp. (OLFC) is pleased to offer its entire line of advanced natural medicines at a Special Season Price of $ 19.95. Applying topical medicine is just rubbing a small amount of the medicine gel to the end of your nostrils. Just in time for the holiday season so the consumer can have self-help for most ordinary conditions. https://www.noxoinfo.com

Special $19.95 Season Event for All OLFC's Natural Non-Prescription Effective Medicines for Anxiety, Sleep, Sensory and Spectrum Issues As Well As Other Common Conditions
ACCESSWIRE - Thu Dec 10, 2:01AM CST
Olfactory Biosciences' Special Season One Month Only prices are 60% from regular $ 49.95

Latest Medical Discovery from OLFC Lets You Whiff Your Hunger Cravings Away on Any Diet. Maintain Your Loss or Even Lose More with HungerMgmt(TM)
ACCESSWIRE - Thu May 07, 10:00AM CDT
HungerMgmt(TM) Combines the Best of All Worlds for Crushing Cravings and Stopping Overeating with Nanotechnology, Phytochemicals, Phytonutrients,Tyrosine and Dopamine; The Topical Non-prescription Preparation Can Be Used with Any Popular Diet or Your Own; The HungerMgmt(TM) Preparation is Made with Natural Ingredients, and is Effective by Using Advanced Olfaction and Chemoreception; Applying HungerMgmt(TM) is Just Rubbing a Small Amount of the Preparation to the End of Your Nostrils

Nightmares and Bad Dreams May Now Be Eliminated with NOXO from OLFC.
ACCESSWIRE - Mon Apr 20, 5:31AM CDT
American Sleep Association Noted that Nightmares are Extremely Common, and May Affect as Many As 80-90% of People at Some Point in Their Lives: NOXO Odor Defense Pro(TM) Can Eliminate This Problem; German Researchers at the Sleep Laboratory at the Central Institute of Mental Health in Mannheim, Germany Have Found That Sleepers Exposed to Unpleasant or Nauseating Odors During Sleep Experienced a Significant Number of Nightmares and Bad Dreams

OLFC Announced that Its Manufacturing Partner, FFS, has Kosher Certification
ACCESSWIRE - Fri Mar 27, 5:31AM CDT
PHILADELPHIA, PA / ACCESSWIRE / March 27, 2015 / Olfactory Biosciences Corp (PINKSHEETS:OLFC) is pleased to announce that its manufacturing partner FFS has Kosher Certification as well as an FDA approved facility. FFS has the superior technical expertise that is necessary to produce our products. We recognize that the combined talent and enthusiasm of FFS employees is one of our most valuable resources.

OLFC Announces Revolutionary Topical Non-Prescription Natural Medicines for Anxiety, Stress, Sensory issues and Other Common Conditions -- An Answer to Today's Health Care Debacle
PR Newswire - Thu Jan 15, 8:47AM CST
Olfactory Biosciences Corp. (OLFC) is pleased to announce 9 revolutionary New Age Medicines for 2015. The new products use natural ingredients, advanced Olfaction and chemoreception. Applying topical medicine is just rubbing a small amount of the medicine balm to the end of your nostrils.

OLFC Announces Innovative New Age Topical Non-Prescription Natural Medicines For Common Conditions. An Answer to Today's Health Care Debacle
ACCESSWIRE - Fri Jan 09, 5:30AM CST
CONSUMER HEAL THYSELF Now is the time when consumers must stop acting like meek victims of government health care plans and take charge. The New Age of Medicine is all about CONSUMER HEAL THYSELF. Olfactory Biosciences is just in time to deliver affordable and non-prescription natural medicines so that the consumer can, in fact, have self-help medicine for most common conditions

OLFC Puts You in a Great Mood for the Holidays
ACCESSWIRE - Tue Dec 09, 5:02AM CST
Philadelphia, PA / ACCESSWIRE / December 9, 2014 / Olfactory Biosciences Corp (OLFC) is pleased to announce a special Holiday Edition of NOXO Mood Boost. The improved NOXO "New Age Medicine" product uses natural ingredients, advanced olfaction and chemoreception and no aromatherapy. Applying topical NOXO is just rubbing a small amount of the balm to the end of your nostrils.

Autism, ADHD, Asperger's Syndrome, Brain & Nervous System, Behavioral issues, Mental Health and Rett Syndrome Helped with NOXO Topical Meds. OLFC Announces Up to 50% Discount until Dec 15, 2014
ACCESSWIRE - Thu Nov 20, 5:01AM CST
PHILADELPHIA, PA /ACCESSWIRE / November 20, 2014 / Olfactory Biosciences Corp (OTC : OLFC) is pleased to announce one month discounts on new cutting edge Next Generation Meds that use natural ingredients, advanced Olfaction and chemoreception. Applying NOXO is just rubbing a small amount of the balm to the end of your nostrils. www.noxoinfo.com

OLFC Announces Next Generation NOXO Alternative Medical Products Lineup for 2015 using Natural Ingredients and Advanced Olfaction and Chemoreception
ACCESSWIRE - Mon Nov 10, 5:01AM CST
Philadelphia, PA / ACCESSWIRE / November 10, 2014 / Olfactory Biosciences Corp (OTC: OLFC ) is pleased to announce 9 new cutting edge Next Generation Alternative Wellness products for 2015. The improved NOXO products use natural ingredients, advanced Olfaction and chemoreception. Applying topical NOXO is just rubbing a small amount of the balm to the end of your nostrils. www.noxoinfo.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading

Top 5 Most Recently Viewed Articles

Celcuity Inc. Prepares for Third Quarter Financial Results

Updated Category News Views 91

Celcuity Inc. Announces Upcoming Financial Results Release Celcuity Inc. (NASDAQ: CELC), a pioneering biotechnology company focused on innovative oncology therapies, has exciting news. The company will be releasing its financial results for the third quarter of 2025 after the market closes. This significant event is scheduled for a Wednesday, with management set to...

Continue Reading
EverTrue and DonorSearch Team Up to Revolutionize Fundraising

Updated Category News Views 973

EverTrue's Strategic Acquisition of DonorSearch EverTrue, a leader in donor engagement and pipeline development, recently announced a significant acquisition. The company has acquired DonorSearch, known for its innovative AI-powered donor discovery solutions. This strategic move is aimed at enhancing the capabilities of fundraising teams, enabling them to connect with...

Continue Reading
Celebrating Creativity and Inclusion: ADCOLOR Awards 2025

Updated Category News Views 315

ADCOLOR Awards 2025: A Night of Inspiration and Celebration Presented by leading organizations in the industry like Amazon, Disney, and Meta, the ADCOLOR Awards is a prestigious event celebrating remarkable individuals and organizations that champion diversity and inclusion in creative fields. This year's ceremony showcased inspiring figures such as Richelieu Dennis,...

Continue Reading
Transforming a $1000 Investment in First Solar to $3700

Updated Category News Views 161

Transform Your Investment with First Solar First Solar (NASDAQ: FSLR) has shown impressive performance over the past decade. This company has not only managed to keep pace with the market but has actually outperformed it by an average of 2.49% annually. This impressive annualized return translates to an average annual growth of 14.22%, making First Solar a notable player...

Continue Reading
Carpenter Technology Announces New Quarterly Dividend Plans

Updated Category News Views 107

Carpenter Technology Announces Quarterly Cash Dividend Carpenter Technology Corporation (NYSE: CRS), a leading name in high-performance specialty alloys, has made a significant announcement regarding its quarterly cash dividend. The company's Board of Directors has declared a dividend of $0.20 per share on common stock, underscoring its commitment to returning value to...

Continue Reading